Page 73 - Read Online

Zhang et al. Late recurrence of hepatocellular carcinoma

Review Board did not require patient consent for this 2007;39:2308-10.
study. 16. Varona MA, Soriano A, Aguirre-Jaime A, Garrido S, Oton E,
Diaz D, Portero J, Bravo P, Barrera MA, Perera A. Risk factors
Ethics approval of hepatocellular carcinoma recurrence after liver transplantation:
accuracy of the alpha-fetoprotein model in a single-center experience.
This study was approved by the Institutional Review Transplant Proc 2015;47:84-9.
Board at the University of Hawaii. 17. Lai Q, Avolio AW, Lerut J, Singh G, Chan SC, Berloco PB, Tisone
G, Agnes S, Chok KS, Sharr W, Rossi M, Manzia TM, Lo CM.
REFERENCES Recurrence of hepatocellular cancer after liver transplantation: the
role of primary resection and salvage transplantation in East and
West. J Hepatol 2012;57:974-9.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo
M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality 18. Chan KM, Chou HS, Wu TJ, Lee CF, Yu MC, Lee WC.
worldwide: sources, methods and major patterns in GLOBOCAN Characterization of hepatocellular carcinoma recurrence after liver
2012. Int J Cancer 2015;136:E359-86. transplantation: perioperative prognostic factors, patterns, and
2. Chiao H, Yang CE, Frenette CT. Review on liver transplant for outcome. Asian J Surg 2011;34:128-34.
hepatocellular carcinoma. Transl Center Res 2013;2:472-81. 19. Lai Q, Avolio Aw, Graziadei I, Otto G, Rossi M, Tisone G, Goffette P,
3. Rubin J, Ayoub N, Kaldas F, Saab S. Management of recurrent Vogel W, Pitton MB, Lerut J; European Hepatocellular Cancer Liver
hepatocellular carcinoma in liver transplant recipients: a systematic Transplant Study Group. Alpha-fetoprotein and modified response
review. Exp Clin Transplant 2012;10:531-43. evaluation criteria in solid tumors progression after locoregional
4. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi therapy as predictors of hepatocellular cancer recurrence and death
GE, Krieger NR, Schwarz ME. Recurrence of hepatocellular after transplantation. Liver Transpl 2013;19:1108-18.
carcinoma after liver transplant: patterns and prognosis. Liver 20. Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer
Transpl 2004;10:534-40. DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW. A novel
5. State Cancer Profiles. Available from: www.statecancerprofiles. prognostic nomogram accurately predicts hepatocellular carcinoma
cancer/gov. [Last accessed on December 24, 2016]. recurrence after liver transplantation: analysis of 865 consecutive
6. US Census data: Quick Facts-Hawaii. Avaiblale from: www.census. liver transplant recipients. J Am Coll Surg 2015;220:416-27.
gov. [Last accessed on December 24, 2016]. 21. Parfitt JR, Marotta P, Alghamdi M, Wall W, Khakhar A, Suskin NG,
7. Wong LL, Hernandez B, Kwee S, Albright CL, Okimoto G, Tsai Quan D, McAllister V, Ghent C, Levstik M, McLean C, Chakrabarti
N. Healthcare disparities in Asians and Pacific Islanders with S, Garcia B, Driman DK. Recurrent hepatocellular carcinoma after
transplantation: use of a pathological score on explanted livers to
hepatocellular cancer. Am J Surg 2012;203:726-32. predict recurrence. Liver Transpl 2007;13:543-51.
8. Bruix J, Sherman M, American Association for the Study of the 22. Oligane HC, Xing M, Kim HS. Effect of bridging local-regional
Liver Disease. Management of hepatocellular carcinoma: an update. therapy on recurrence of hepatocellular carcinoma and survival after
Hepatology 2011;53:1020-2.
orthotopic liver transplantation. Radiology 2017;282:869-79.
9. Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung 23. Chok KS, Chan SC, Cheung TT, Chan AC, Fan ST, Lo CM. Late
DH, Park GC, Yu YD, Park PJ, Choi YI, Kim KW, Lim YS, Lee recurrence of hepatocellular carcinoma after liver transplantation.
HC, Yu ES, Lee SG. Super-selection of a subgroup of hepatocellular World J Surg 2011;35:2058-62.
carcinoma patients at minimal risk of recurrence for LT. J 24. Toso C, Cader S, Mentha-Dugerdil A, Meeberg G, Majno P, Morard
Gastrointest Surg 2011;15:971-81. I, Giostra E, Berney T, Morel P, Mentha G, Kneteman NM. Factors
10. Lee S, Hyuck David Kwon C, Man Kim J, Joh JW, Woon Paik predicting survival after post-transplant hepatocellular carcinoma
S, Kim BW, Wang HJ, Lee KW, Suh KS, Lee SK. Time of recurrence. J Hepatobiliary Pancreat Sci 2013;20:342-7.
hepatocellular carcinoma recurrence after liver resection and alpha- 25. Shin WY, Suh KS, Lee HW, Kim J, Kim T, Yi NJ, Lee KU.
fetoprotein are important prognostic factors for salvage liver Prognostic factors affecting survival after recurrence in adult living
transplantation. Liver Transpl 2014;20:1057-63. donor transplantation for hepatocellular carcinoma. Liver Transpl
11. Schraiber Ldos S, de Mattos AA, Zanotelli ML, Cantisani GP, 2010;16:678-84.
Brandão AB, Marroni CA, Kiss G, Ernani L, Marcon Pdos S. 26. Zou WL, Zang YJ, Chen XG, Shen ZY. Risk factors for fatal
Alpha-fetoprotein level predicts recurrence after transplantation in recurrence of hepatocellular carcinoma and their role in selecting
hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e2478. candidates for liver transplantation. Hepatobiliary Pancreat Dis Int
12. Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN. Rate of 2008;7:145-51.
tumor growth predicts recurrence of hepatocellular carcinoma after 27. Rodriguez-Peralvarez M, Tsochatzis E, Naveas MC, Pieri G, Garcia-
LT in patients beyond Milan or UCSF criteria. Transplant Proc Caparros C, O’Beirne J, Poyato-Gonzalez A, Ferrin-Sanchez G,
2011;43:3813-8. Montero-Alvarez JL, Patch D, Thorburn D, Briceno J, De la Mata M,
13. Andreou A, Bahra M, Schmelzle M, Öllinger R, Sucher R, Sauer IM, Burroughs AK. Reduced exposure to calcineurin inhibitors early after
Guel-Klein S, Struecker B, Eurich D, Klein F, Pascher A, Pratschke liver transplantation prevents recurrence of hepatocellular carcinoma.
J, Seehofer D. Predictive factors for extrahepatic recurrence of J Hepatol 2013;59:1193-9.
hepatocellular carcinoma following liver transplantation. Clin 28. Nissen NN, Menon V, Bresee C, Tran TT, Annamalai A, Poordad
Transplant 2016;30:819-27. F, Fair JH, Klein AS, Boland B, Colquhoun SD. Recurrent
14. Kondili LA, Lala A, Gunson B, Hubscher S, Olliff S, Elias E, hepatocellular carcinoma after liver transplant: identifying the high-
Bramhall S, Mutimer D. Primary hepatocellular cancer in the risk patient. HPB (Oxford) 2011;13:626-32.
explanted liver: outcome of transplantation and risk factors for HCC 29. Pfiffer TB, Seehofer D, Nicolaou A, Neuhaus R, Riess H, Trappe
recurrence. Eur J Surg Oncol 2007;33:868-73. RU. Recurrent hepatocellular carcinoma in liver transplant recipients:
15. Escartin A, Sapisochin G, Bilbao I, Vilallonga R, Bueno J, Castells parameters affecting time to recurrence, treatment options and
L, Dopazo C, Castro E, Caralt M, Balsells J. Recurrence of survival in the sorafenib era. Tumori 2011;97:436-41.
hepatocellular carcinoma after liver transplantation. Transplant Proc 30. Marelli L, Grasso A, Pleguezuelo M, Martines H, Stigliano R,
Hepatoma Research ¦ Volume 3 ¦ April 10, 2017 65